莱美药业 (300006.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(莱美药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 605,644,339.58381,747,437.18181,120,476.19895,592,665.42644,756,058.18453,859,975.46226,654,528.42
 营业收入(元) 605,644,339.58381,747,437.18181,120,476.19895,592,665.42644,756,058.18453,859,975.46226,654,528.42
二、营业总成本(元) 659,835,849.32412,379,212.20190,903,145.49972,707,004.69684,021,711.19477,078,919.79238,539,547.44
 营业成本(元) 221,662,241.70133,242,350.3263,725,646.12274,678,187.58198,114,541.29136,263,746.3466,225,687.95
 研发费用(元) 44,369,887.6925,908,699.1010,297,554.5699,810,491.2253,968,857.0033,934,986.9715,677,120.11
 营业税金及附加(元) 14,105,878.028,991,523.054,115,543.2619,418,955.6814,388,027.7910,038,295.815,195,150.33
 销售费用(元) 299,437,003.09190,748,101.0987,901,058.33462,002,232.59332,057,579.99240,919,142.11125,911,823.69
 管理费用(元) 94,248,180.7463,941,009.3730,292,810.48139,406,060.27103,673,404.0569,609,191.7528,511,081.40
 财务费用(元) -13,987,341.92-10,452,470.73-5,429,467.26-22,608,922.65-18,180,698.93-13,686,443.19-2,981,316.04
  其中:利息费用(元) 7,892,894.425,015,425.652,570,705.6212,471,274.119,591,763.026,606,408.033,104,884.97
  其中:利息收入(元) 22,589,630.9415,314,061.637,956,018.1334,636,239.9927,035,213.7119,377,078.676,543,779.03
三、其他经营收益
 加:投资收益(元) -17,722,492.92-9,576,571.52-5,537,147.8387,019,510.13722,553.22-1,601,618.43-678,990.63
  其中:对联营企业和合营企业的投资收益(元) -18,706,419.75-10,429,061.77-5,833,380.95-24,888,134.00426,320.10-1,601,618.43-678,990.63
 资产处置收益(元) 65,503.6910,015.848,006.35446,091.90---
 资产减值损失(元) -2,904,015.43-427,817.88-110,828.74-5,042,469.07-3,701,592.39-2,729,350.97-45,428.01
 信用减值损失(元) -5,408,968.14-2,138,112.12-2,640,184.15-3,662,220.43-8,260,187.81-6,474,000.84-1,556,646.18
 其他收益(元) 39,354,646.6929,388,675.5419,870,791.4754,580,115.7437,709,326.7819,570,515.1310,930,854.65
四、营业利润(元) -40,806,835.85-13,375,585.161,807,967.8056,226,689.00-12,795,553.21-14,453,399.44-3,235,229.19
 加:营业外收入(元) 30,360,820.7830,187,410.434,271.79328,302.6279,543.563,365.6252.41
 减:营业外支出(元) 252,244.87128,767.9943,699.1052,960,651.9952,279,931.8752,042,130.0765,771.45
五、利润总额(元) -10,698,259.9416,683,057.281,768,540.493,594,339.63-64,995,941.52-66,492,163.89-3,300,948.23
 减:所得税费用(元) 4,824,830.067,894,065.761,737,162.4913,612,118.73-1,029,731.90-3,434,290.464,305,102.10
六、净利润(元) -15,523,090.008,788,991.5231,378.00-10,017,779.10-63,966,209.62-63,057,873.43-7,606,050.33
(一)按经营持续性分类
  持续经营净利润(元) -15,508,670.558,788,991.5231,378.00-10,017,779.10-63,966,209.62-63,057,873.43-7,606,050.33
  终止经营净利润(元) -14,419.45------
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -26,416,692.101,328,168.01-4,575,299.38-8,927,328.47-54,513,800.64-54,056,871.17-3,634,060.91
  少数股东损益(元) 10,893,602.107,460,823.514,606,677.38-1,090,450.63-9,452,408.98-9,001,002.26-3,971,989.42
 扣除非经常性损益后的净利润(元) -55,643,185.24-27,567,168.28-7,433,735.21-59,933,329.21-27,829,716.94-19,215,453.63-8,861,681.82
七、每股收益
 一、基本每股收益(元) -0.03---0.01-0.05-0.05-
 二、稀释每股收益(元) -0.03---0.01-0.05-0.05-
八、其他综合收益(元) ----43,771,919.62---
 归属于母公司股东的其他综合收益(元) ----43,771,919.62---
九、综合收益总额(元) -15,523,090.008,788,991.5231,378.00-53,789,698.72-63,966,209.62-63,057,873.43-7,606,050.33
 归属于母公司所有者的综合收益总额(元) -26,416,692.101,328,168.01-4,575,299.38-52,699,248.09-54,513,800.64-54,056,871.17-3,634,060.91
 归属于少数股东的综合收益总额(元) 10,893,602.107,460,823.514,606,677.38-1,090,450.63-9,452,408.98-9,001,002.26-3,971,989.42
公告日期 2024-10-232024-08-242024-04-242024-03-232023-10-212023-08-242023-04-22
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院